Asymptomatic Subcutaneous Semaglutide Overdose: A Case Report and Literature Review

Courtney B. Diec, Elizabeth A. Cook, Nguyet T. Nguyen, Department of Pharmacy Practice, University of Kansas School of Pharmacy, Department of Pharmacy - Clinical Services, Robert J. Dole Veterans Affairs Medical Center

Journal of Pharmacy Practice

Published online on April 15, 2025

Abstract

Journal of Pharmacy Practice, Volume 39, Issue 3, Page 219-224, June 2026.
Semaglutide is a glucagon-like-peptide-1 receptor agonist (GLP-1 RA) that is approved for the treatment of type 2 diabetes mellitus (T2DM) and obesity. Common adverse drug reactions (ADR) of semaglutide include nausea, vomiting, abdominal pain, ...